Clariant AG CLN.SW
Composite 50/100; the shares have moved about 40% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Growth ranks 18/100 — a strong mark against it.
Momentum ranks 82/100 — a strong point in its favour. Valuation ranks 60/100 — a slight point in its favour. Balance-sheet strength ranks 54/100 — a slight point in its favour.
Growth ranks 18/100 — a strong mark against it. Quality ranks 40/100 — a slight mark against it.
What the company does Clariant AG is a Swiss specialty chemicals group organized into three segments: Care Chemicals (home/personal care, crop solutions), Catalysts (propylene, ethylene, syngas), and Adsorbents & Additives (coatings, adhesives, electronics). It serves agriculture, coatings, adhesives, automotive, and mining globally.
Key financials Clariant’s trailing ROE is -1.8% and ROA is 4.0%, with gross margin 31.2% and operating margin 18.8%. Revenue fell -7.1% and EPS dropped -83.4%. Debt/equity is 0.93 and net debt/EBITDA is 2.40; dividend yield is 5.7% with a 123.5% payout.
Stock health Sideravia scores Clariant’s overall quality at the 42.8th percentile (“Poor quality, attractively valued”), with strength at 49.1 and valuation at 73.8. Piotroski F-Score is 3/9 and RSI(14) is 57.60.
Price vs fair value The stock trades at a PREMIUM of 21.20% to our fair-value estimate of 6.05 and at a discount of 10.33% to the 12-month target of 8.46. - Gross margin 31.2% and FCF yield 9.9% support valuation appeal (Valuation 73.8). - ROE -1.8% and EPS growth -83.4% reflect weak profitability and growth (Quality 26.9, Growth 12.0). - Debt/equity 0.93 and payout 123.5% raise balance-sheet and sustainability concerns.
Looking forward Forward P/E is 11.98 and EV/EBITDA is 10.09, but PEG is n/a due to negative EPS growth. Momentum is mixed: +11.40% over six months but -9.11% over twelve months.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-05, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.